1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Malaria
1.2.3 Ebola
1.2.4 Dengue
1.2.5 Chagas
1.2.6 Leishmaniasis
1.2.7 Other
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drugs
1.3.3 Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2017-2028)
2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Region (2017-2022)
2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2023-2028)
2.3 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
2.3.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2017-2022)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2017-2022)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2021
3.5 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
3.7 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2017-2022)
4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2023-2028)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2017-2022)
5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
6.2.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)
6.2.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028)
6.2.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2017-2028)
6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
6.3.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)
6.3.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028)
6.3.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2017-2028)
6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
6.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
6.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
7.2.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)
7.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028)
7.2.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2017-2028)
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
7.3.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)
7.3.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028)
7.3.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2017-2028)
7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
7.4.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
7.4.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
8.2.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2017-2028)
8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
8.3.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2017-2028)
8.4 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.4.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
9.2.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)
9.2.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028)
9.2.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2017-2028)
9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
9.3.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)
9.3.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028)
9.3.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2017-2028)
9.4 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
9.4.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
9.4.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
10.2.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2017-2028)
10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
10.3.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2017-2028)
10.4 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
10.4.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Artecef BV
11.1.1 Artecef BV Company Details
11.1.2 Artecef BV Business Overview
11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.1.5 Artecef BV Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.2.5 GlaxoSmithKline Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.3.5 AstraZeneca Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Details
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.5.5 Sanofi-Aventis Recent Developments
11.6 Ranbaxy Labs
11.6.1 Ranbaxy Labs Company Details
11.6.2 Ranbaxy Labs Business Overview
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.6.5 Ranbaxy Labs Recent Developments
11.7 Lupin
11.7.1 Lupin Company Details
11.7.2 Lupin Business Overview
11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.7.5 Lupin Recent Developments
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Details
11.8.2 Macleods Pharmaceuticals Business Overview
11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.8.5 Macleods Pharmaceuticals Recent Developments
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.9.5 Cipla Recent Developments
11.10 Romark Laboratories
11.10.1 Romark Laboratories Company Details
11.10.2 Romark Laboratories Business Overview
11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.10.5 Romark Laboratories Recent Developments
11.11 Toyama Chemica
11.11.1 Toyama Chemica Company Details
11.11.2 Toyama Chemica Business Overview
11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
11.11.5 Toyama Chemica Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Malaria
Table 3. Key Players of Ebola
Table 4. Key Players of Dengue
Table 5. Key Players of Chagas
Table 6. Key Players of Leishmaniasis
Table 7. Key Players of Other
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2017-2022)
Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2023-2028)
Table 14. Neglected Tropical Diseases Drugs and Vaccine Market Trends
Table 15. Neglected Tropical Diseases Drugs and Vaccine Market Drivers
Table 16. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 17. Neglected Tropical Diseases Drugs and Vaccine Market Restraints
Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Players (2017-2022)
Table 20. Global Top Neglected Tropical Diseases Drugs and Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2021)
Table 21. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
Table 25. Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2017-2022)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2023-2028)
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2017-2022)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Application (2023-2028)
Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 65. Artecef BV Company Details
Table 66. Artecef BV Business Overview
Table 67. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product
Table 68. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 69. Artecef BV Recent Developments
Table 70. GlaxoSmithKline Company Details
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product
Table 73. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 74. GlaxoSmithKline Recent Developments
Table 75. AstraZeneca Company Details
Table 76. AstraZeneca Business Overview
Table 77. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product
Table 78. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 79. AstraZeneca Recent Developments
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Neglected Tropical Diseases Drugs and Vaccine Product
Table 83. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 84. Novartis Recent Developments
Table 85. Sanofi-Aventis Company Details
Table 86. Sanofi-Aventis Business Overview
Table 87. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product
Table 88. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 89. Sanofi-Aventis Recent Developments
Table 90. Ranbaxy Labs Company Details
Table 91. Ranbaxy Labs Business Overview
Table 92. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product
Table 93. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 94. Ranbaxy Labs Recent Developments
Table 95. Lupin Company Details
Table 96. Lupin Business Overview
Table 97. Lupin Neglected Tropical Diseases Drugs and Vaccine Product
Table 98. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 99. Lupin Recent Developments
Table 100. Macleods Pharmaceuticals Company Details
Table 101. Macleods Pharmaceuticals Business Overview
Table 102. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product
Table 103. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 104. Macleods Pharmaceuticals Recent Developments
Table 105. Cipla Company Details
Table 106. Cipla Business Overview
Table 107. Cipla Neglected Tropical Diseases Drugs and Vaccine Product
Table 108. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 109. Cipla Recent Developments
Table 110. Romark Laboratories Company Details
Table 111. Romark Laboratories Business Overview
Table 112. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product
Table 113. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 114. Romark Laboratories Recent Developments
Table 115. Toyama Chemica Company Details
Table 116. Toyama Chemica Business Overview
Table 117. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product
Table 118. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
Table 119. Toyama Chemica Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2021 VS 2028
Figure 2. Malaria Features
Figure 3. Ebola Features
Figure 4. Dengue Features
Figure 5. Chagas Features
Figure 6. Leishmaniasis Features
Figure 7. Other Features
Figure 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2021 VS 2028
Figure 9. Drugs Case Studies
Figure 10. Vaccines Case Studies
Figure 11. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region: 2021 VS 2028
Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2021
Figure 16. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2021
Figure 18. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2028)
Figure 20. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2028)
Figure 21. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Country (2017-2028)
Figure 22. United States Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2028)
Figure 26. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2028)
Figure 27. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Country (2017-2028)
Figure 28. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Region (2017-2028)
Figure 38. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Country (2017-2028)
Figure 48. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Country (2017-2028)
Figure 54. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 59. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 60. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 61. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 62. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 63. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 64. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 65. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 66. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 67. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
